Table 3.
Baseline patient characteristics (N = 28)
| Characteristic | Mean (± standard deviation) | N (%) |
|---|---|---|
| Age, years | 54.1 (10.2) | |
| Race/ethnicity | Caucasian | 13 (45) |
| Asian | 1 (7) | |
| Hispanic | 9 (30) | |
| African American | 2 (8) | |
| Other | 3 (10) | |
| Tobacco use | Never | 14 (50) |
| Current | 1 (5) | |
| Past | 13 (45) | |
| Marital status | Married | 23 (80) |
| Single/divorced | 4 (15) | |
| Widowed | 1 (5) | |
| Education level | High school or equivalent | 10 (35) |
| College or postgraduate degree | 15 (55) | |
| Other | 3 (10) | |
| Employment status | Full-time | 16 (60) |
| Part-time | 6 (20) | |
| Retired | 6 (20) | |
| Cancer stage | I | 11 (40) |
| II | 14 (50) | |
| III | 3 (10) | |
| Surgery type | Mastectomy | 13 (45) |
| Lumpectomy | 10 (35) | |
| N/A (neoadjuvant chemo) | 5 (20) | |
| Chemotherapy type | Doxorubicin/cyclophosphamide + paclitaxel | 13 (42) |
| Docetaxel/cyclophosphamide | 11 (36) | |
| Carboplatin + paclitaxel | 2 (9) | |
| Doxorubicin/cyclophosphamide | 1 (7) | |
| Docetaxel/cyclophosphamide/trastuzumab | 1 (6) | |
| Diabetes status | Free from disease | 4 (15) |
| Pre-diabetic | 18 (64) | |
| Diabetic | 6 (21) |